| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/10/2011 | CN101292953B Medicament automatic release system preparation method based on conductive polymer polypyrrole |
| 08/10/2011 | CN101265304B Bionic chitosan derivatives, preparation method thereof and lipoid plastid preparation containing the same |
| 08/10/2011 | CN101254246B External-used burn and scald treating medicine and its preparation |
| 08/10/2011 | CN101239065B Method for preparing cefepime dihydrochloride and L-arginine mixed powder |
| 08/10/2011 | CN101234216B Collagen base freezing gel suitable for biological medical material and preparation thereof |
| 08/10/2011 | CN101194907B Dropping pills containing noscapine and method for preparing the same |
| 08/10/2011 | CN101194904B Dropping pills containing perhexiline maleic acid and method for preparing the same |
| 08/10/2011 | CN101194894B Dropping pills containing tegaserod maleate and method for preparing the same |
| 08/10/2011 | CN101085145B Traditional Chinese medicine composition containing red sage root, dioscorea panthaica or huangyangning and its preparation |
| 08/10/2011 | CN101084015B Antibody formulation in histidine-acetate buffer |
| 08/09/2011 | US7994272 Maleamic acid polymer derivatives and their bioconjugates |
| 08/09/2011 | US7994227 Nanoparticulate active substance formulations |
| 08/09/2011 | US7994224 Sprayable aerosol paint composition with 3-iodo-2-propynyl butyl carbamate fungicide and a vinyl toluene alkyd resin |
| 08/09/2011 | US7994213 Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith |
| 08/09/2011 | US7994188 Compounds for treating inflammatory diseases |
| 08/09/2011 | US7994135 Antibodies conjugated to Auristatin analogs via a maleimidocaproyl lingages; for treating cancer, autoimmune diseases and infectious diseases |
| 08/09/2011 | US7994134 Peptide-based compounds |
| 08/09/2011 | US7994120 Method of treating dyslipidemic disorder |
| 08/09/2011 | US7993679 Flowable wound matrix and its preparation and use |
| 08/09/2011 | US7993677 Density-controlled particulate suspensions for foodstuff, cosmetic, pharmaceutical and other uses |
| 08/09/2011 | US7993676 Free-flowing, powdery composition containing alpha-liponic acid (derivates) |
| 08/09/2011 | US7993671 Blend of: (a) one or more polymers; and (b) a drug that is liquid ad room temperature; free of water and other low boiling liquids; pressure-sensitive transdermal drug delivery system |
| 08/09/2011 | US7993669 synergistic efficacy; polar lipid supplement, a soluble fiber, and a nutricine such as threonine |
| 08/09/2011 | US7993668 Nutrient composition and composition for prevention/mitigation of digestive tract depression |
| 08/09/2011 | US7993631 Oil base and external preparation containing same |
| 08/09/2011 | CA2634664C Novel albumin-free factor viii formulations |
| 08/09/2011 | CA2605127C Soluble non-caloric fiber composition and process of preparing the same |
| 08/09/2011 | CA2518918C Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| 08/09/2011 | CA2508281C Method for producing sterile polynucleotide based medicaments |
| 08/09/2011 | CA2500712C Antibiotic pharmaceutical composition with improved oral absorbability |
| 08/09/2011 | CA2483786C Preparations for the topical application of anti-androgenically active substances |
| 08/09/2011 | CA2474645C Compositions and methods for systemic inhibition of cartilage degradation |
| 08/09/2011 | CA2463938C Polymer conjugates of opioid antagonists |
| 08/09/2011 | CA2451377C Oral pharmaceutical compositions with improved bioavailability |
| 08/09/2011 | CA2448927C Pharmaceutical composition |
| 08/09/2011 | CA2441146C Fluorescent cobalamins and uses thereof |
| 08/09/2011 | CA2434484C Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances |
| 08/09/2011 | CA2407415C Chondroitin synthase gene and methods of making and using same |
| 08/09/2011 | CA2380058C Novel peptides |
| 08/09/2011 | CA2267210C Method of stabilizing useful protein and useful protein composition |
| 08/09/2011 | CA2243559C Pharmaceutical composition for immunomodulation |
| 08/09/2011 | CA2237995C Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 08/04/2011 | WO2011094671A2 N-terminally conjugated polypeptides for targeted therapy and diagnosis |
| 08/04/2011 | WO2011093833A2 Effervescent formulations comprising second generation cephalosporin |
| 08/04/2011 | WO2011093535A1 Matrix pharmaceutical composition containing galantamine |
| 08/04/2011 | WO2011093470A1 Pharmaceutical composition for treatment of bone diseases, which contains protein comprising bone morphogenetic protein receptor 1b (bmpr1b) extracellular domain or mutant thereof |
| 08/04/2011 | WO2011093416A1 Pharmaceutical composition and preparation for oral administration |
| 08/04/2011 | WO2011093083A1 Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
| 08/04/2011 | WO2011092675A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination |
| 08/04/2011 | WO2011092551A1 Antimicrobial composition |
| 08/04/2011 | WO2011038356A3 Novel liver-targeting agents and their synthesis |
| 08/04/2011 | WO2011031621A3 High strength seamless alginate capsules |
| 08/04/2011 | WO2011019685A3 Second generation fatty acid compositions, formulations, and methods of use and synthesis thereof |
| 08/04/2011 | WO2011017382A3 Nanofibers and morphology shifting micelles |
| 08/04/2011 | WO2010151653A3 Terpene glycosides and their combinations as solubilizing agents |
| 08/04/2011 | WO2008133534A3 Carbohydrate-lipid constructs and their use in preventing or treating viral infection |
| 08/04/2011 | US20110190401 Depolymerized polysaccharide-based hydrogel adhesive and methods of use thereof |
| 08/04/2011 | US20110190238 Modifications of solid 3-sn-phosphoglycerides |
| 08/04/2011 | US20110190224 Non-Viral Delivery of Compounds to Mitochondria |
| 08/04/2011 | US20110190205 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 08/04/2011 | US20110190203 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 08/04/2011 | US20110189298 Double emulsion and method to produce such |
| 08/04/2011 | US20110189265 Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias |
| 08/04/2011 | US20110189261 Transdermally absorbable preparation |
| 08/04/2011 | US20110189253 Biomaterial composition and method |
| 08/04/2011 | US20110189245 Smooth, High Solids Tablet Coating Composition |
| 08/04/2011 | US20110189244 Appetising medicament for oral administration in solid form |
| 08/04/2011 | US20110189242 Oral galenic form, polymer production method and use of same |
| 08/04/2011 | US20110189108 Use of 1-(2,4-dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-one |
| 08/04/2011 | US20110189105 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 08/04/2011 | US20110187015 System and method for uniaxial compression of an article, such as a three dimensionally printed dosage form |
| 08/04/2011 | CA2788527A1 Pharmaceutical composition for osteoarthritis treatment or prevention and manufacturing method therefor |
| 08/03/2011 | EP2351852A1 RNA interference mediating small RNA molecules |
| 08/03/2011 | EP2351844A1 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells |
| 08/03/2011 | EP2351586A1 Pharmaceutical compositions of active polypeptides for enhanced pharmacological activity through oral and parenteral administration |
| 08/03/2011 | EP2351567A2 Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351557A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom |
| 08/03/2011 | EP2351556A2 Encapsulated functional fine particle composition capable of spraying and preparation method thereof |
| 08/03/2011 | EP2350649A1 Stable antibody compositions and methods for stabilizing same |
| 08/03/2011 | EP2350168A1 Polysaccharide- and polypeptide-based block copolymers, vesicles constituted of these copolymers and use thereof |
| 08/03/2011 | EP2349347A2 Hpma - docetaxel or gemcitabine conjugates and uses therefore |
| 08/03/2011 | EP2349346A1 Compositions and methods for achieving sustained therapeutic drug concentrations in a subject |
| 08/03/2011 | EP2349345A1 Method for the preparation of a controlled release system |
| 08/03/2011 | EP2349344A1 Compounds |
| 08/03/2011 | EP2349343A2 Polymeric composition with synergistic effect in treatment of tumour diseases |
| 08/03/2011 | EP2349342A1 Modified blood factors comprising a low degree of water soluble polymer |
| 08/03/2011 | EP2349341A2 Pegylation of recombinant blood coagulation factors in the presence of bound antibodies |
| 08/03/2011 | EP2349340A2 Stable aqueous formulations of water insoluble or poorly soluble drugs |
| 08/03/2011 | EP2349339A2 Sustained drug delivery system |
| 08/03/2011 | EP2349338A2 Complex consisting of polysaccharide and an hpb |
| 08/03/2011 | EP2349337A1 Formulations for the treatment of acute herpes zoster pain |
| 08/03/2011 | EP2349336A1 Mesoporous material excipients for poorly aqueous soluble ingredients |
| 08/03/2011 | EP2349314A2 Lyophilized recombinant vwf formulations |
| 08/03/2011 | EP2349309A1 Pyrazalone derivative formulations |
| 08/03/2011 | EP2349282A2 Methods of treating pulmonary disorders with liposomal amikacin formulations |
| 08/03/2011 | EP2349248A2 Topical nsaid compositions having sensate component |
| 08/03/2011 | EP2349243A1 Urea-based film-forming solution for treating nail psoriasis |
| 08/03/2011 | EP2349225A1 Microcapsules having an envelope composed essentially of silsesquioxane homopolymers or copolymers |
| 08/03/2011 | EP2349221A2 Sustained release drug delivery system |